IFNB1 and autoimmune disease: The mechanisms underlying the occurrence of DMT-induced DILI and hepatic ADRs in general are varied, ranging from autoimmune disorders (such as in cases associated with beta-interferon) or viral reactivation (such as fingolimod- or natalizumab-induced cases).